PF-Atlas › Mechanisms › TNIK Inhibition (AI-discovered)

TNIK Inhibition (AI-discovered) in IPF

Mechanism of action · idiopathic pulmonary fibrosis

Overview

TNIK Inhibition (AI-discovered) is a therapeutic target in idiopathic pulmonary fibrosis. PF-Atlas tracks 1 drug and 1 clinical trial acting through this mechanism.

Drugs targeting TNIK Inhibition (AI-discovered)

Rentosertib

Clinical trials

Rentosertib — ISM001-055

Medical disclaimer. This is a research summary, not medical advice.